NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Edison International (“Edison” or the “Company”) (NYSE: EIX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Edison International of Class Action Lawsuit and Upcoming Deadlines – EIX
Tag: People
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Venture Global, Inc. of Class Action Lawsuit and Upcoming Deadlines – VG
NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Venture Global, Inc. of Class Action Lawsuit and Upcoming Deadlines – VG
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AppLovin Corporation of Class Action Lawsuit and Upcoming Deadlines – APP
NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AppLovin Corporation of Class Action Lawsuit and Upcoming Deadlines – APP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ready Capital Corporation of Class Action Lawsuit and Upcoming Deadlines – RC
NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Ready Capital Corporation (“Ready” or the “Company”) (NYSE: RC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ready Capital Corporation of Class Action Lawsuit and Upcoming Deadlines – RC
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRVI
NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRVI
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – NTLA
NEW YORK, April 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ: NTLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address,… Continue reading INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – NTLA
@Toyota: Toyota Brings the Need for Speed and Adventure to the New York International Auto Show
From Long Beach to New York City, Toyota’s two new GR special edition vehicles – the GR Supra MkV Final Edition and GR86 Yuzu Special Edition – make its way to the Auto Show, along with several of its latest cars and SUVs NEW YORK (APRIL 14, 2025) – Toyota returns to the 2025 New… Continue reading @Toyota: Toyota Brings the Need for Speed and Adventure to the New York International Auto Show
Apple’s AI-Powered Siri Is Such a Disaster That Employees Have Given the Team Developing It a Rude Nickname
Apple has floundered in its efforts to bring a convincing AI product to the table — so much so that it’s become the subject of derision even among its own employees, The Information reports. More specifically, it’s the AI and machine-learning group that’s getting the lion’s share of mockery. Known as AI/ML for short, its… Continue reading Apple’s AI-Powered Siri Is Such a Disaster That Employees Have Given the Team Developing It a Rude Nickname
Chat Relentlessly Mocks Katy Perry’s “Space Trip”
Tens of thousands of people tuned in to watch a crew of six women, including pop star Katy Perry, and Blue Origin CEO Jeff Bezos’ girlfriend Lauren Sánchez, launch to the outer reaches of the Earth’s atmosphere. The 11-minute mission — which the media breathlessly and erroneously described as the “first all-female space flight” —… Continue reading Chat Relentlessly Mocks Katy Perry’s “Space Trip”
Dr. Alexander Schmidt Appointed Chief Medical Officer and Head of Development of the Gates Medical Research Institute
CAMBRIDGE, Mass., April 14, 2025 /PRNewswire/ — The Gates Medical Research Institute (Gates MRI) today announced the appointment of Alexander Schmidt, MD, PhD, as Chief Medical Officer (CMO) and Head of Development, effective April 1, 2025. He has been serving as interim CMO and Head of Development since January 1, 2025. Continue Reading Alexander Schmidt,… Continue reading Dr. Alexander Schmidt Appointed Chief Medical Officer and Head of Development of the Gates Medical Research Institute